Together, we make a difference
Here's to 25 years of achievements, innovation, and
collaboration. Together, we continue to make a difference for patients around the world.
We are committed to developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with severe and life-threatening bacterial and fungal infections. Basilea is located in the Basel area, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN).
Half-Year Report 2026
"Our goal is to become a leading anti-infectives company and serve patients around the world."
News
Half-Year Report 2026
People are at the heart of everything we do.
CEO Statement
For the benefit of patients around the world, we run Cresemba and Zevtera as truly global brands, while advancing our late-stage clinical assets and continuing to build our pipeline.
Based on our proven expertise in advancing anti-infectives through research and development to the market, we are aiming at becoming a leading anti-infectives company.
